Publications for Gizeh Perez-Tenorio
Co-author map based on ISI articles 2007-
Publications mentioned in social media 4 times*
Keywords
treatment tamoxifen survival s6k2 s6k1 receptor pten protein prognostic pik3ca patients p21 gene cells cancer breast benefit amplification akt2 akt
Journal Articles
Helena Fohlin, Gizeh Perez-Tenorio, Tommy Fornander, Lambert Skoog, Bo Nordenskjöld, John Carstensen and Olle Stål
Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer
European Journal of Cancer, 2013, 49(6), 1196-1204.
Fulltext  Web of Science® Times Cited: 1 |
Elin Karlsson, Gizeh Pérez-Tenorio, Risul Amin, Josefine Bostner, Lambert Skoog, Tommy Fornander, Dennis C Sgroi, Bo Nordenskjöld, Anna-Lotta Hallbeck and Olle Stål
The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials.
Breast Cancer Research, 2013, 15(5), R96.
Fulltext |
Gizeh Perez-Tenorio, Elin Karlsson, Marie Ahnström, Birgit Olsson, Birgitta Holmlund, Bo Nordenskjöld, Tommy Fornander, Lambert Skoog and Olle Stål
Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer
Breast Cancer Research and Treatment, 2011, 128(3), 713-723.
Fulltext Web of Science® Times Cited: 7 |
Elin Karlsson, Marie Ahnström, Josefine Bostner, Gizeh Perez-Tenorio, Birgit Olsson, Anna-Lotta Hallbeck and Olle Stål
High-Resolution Genomic Analysis of the 11q13 Amplicon in Breast Cancers Identifies Synergy with 8p12 Amplification, Involving the mTOR Targets S6K2 and 4EBP1
Genes, Chromosomes and Cancer, 2011, 50(10), 775-787.
Fulltext Web of Science® Times Cited: 11 |
Todd W Miller, Archana Narasanna, Gizeh Perez-Tenorio, Ana M Gonzalez-Angulo, Bryan T Hennessy, Gordon B Mills, J Phillip Kennedy, Craig W Lindsley and Carlos L Arteaga
Loss of Phosphatase and Tensin Homologue Deleted on Chromosome 10 Engages ErbB3 and Insulin-Like Growth Factor-I Receptor Signaling to Promote Antiestrogen Resistance in Breast Cancer
CANCER RESEARCH, 2009, 69(10), 4192-4201.
Web of Science® Times Cited: 54 |
Gizeh Perez-Tenorio, Elin Karlsson, Marie Ahnström Waltersson, Birgit Olsson, Birgitta Holmlund, Bo Nordenskjöld, Tommy Fornander, Lambert Skoog and Olle Stål
Clinical Value of RPS6KB1 and RPS6KB2 Gene Amplification in Postmenopausal Breast Cancer
, 2008, , .
|
Gizeh Pérez-Tenorio, Liza Alkhori, Birgit Olsson, Marie Ahnstro Waltersson, Bo Nordenskjöld, Lars Erik Rutqvist, Lambert Skoog and Olle Stål
PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer
Clinical Cancer Research, 2007, 13(12), 3577-3584.
Web of Science® Times Cited: 109 |
Gizeh Perez-Tenorio, Fredrik Berglund, Anna Esguerra Merca, Bo Nordenskjöld, Lars Erik Rutqvist, Lambert Skoog and Olle Stål
Cytoplasmic p21WAF1/CIP1 correlates with Akt activation and poor response to tamoxifen in breast cancer
International Journal of Oncology, 2006, 28(5), 1031-1042.
Web of Science® Times Cited: 22 |
Karin Söderlund Leifler, Gizeh Pérez-Tenorio and Olle Stål
Activation of the phosphatidylinositol 3-kinase/Akt pathway prevents radiation-induced apoptosis in breast cancer cells
International Journal of Oncology, 2005, 26(1), 25-32.
Web of Science® Times Cited: 29 |
Olle Stål, Gizeh Perez-Tenorio, Lind Åkerberg, Birgit Olsson, Bo Nordenskjöld, Lambert Skoog and Lars Rutqvist
Akt kinases in breast cancer and the results of adjuvant therapy
Breast Cancer Research, 2003, 5(2), R37-R44.
Web of Science® Times Cited: 95 |
Gizeh Pérez-Tenorio, Olle Stål and Members of the Southeast Sweden Breast Cancer Group
Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients
British Journal of Cancer, 2002, 86(4), 540-545.
Web of Science® Times Cited: 236 |
Conference Articles
Ph.D. Theses
* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.
Ph.D., Lic. Theses
